NASDAQ:IMVT

Immunovant, Inc Earning Date

USA |NASDAQ |USD

IMVT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $-0.28 $-0.31 $-0.25
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $0.00 $0.00 $0.00

Immunovant, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

IMVT Earnings Date & History Chart

IMVT Earnings & Revenue Forecast

IMVT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $-0.29 $-0.35 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 9 $-1.57 $-4.48 $-1.08
Mar 2023 7 $-1.33 $-1.61 $-1.12

IMVT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.29 $-0.29 $-0.33
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Mar 2022 0 / 0 $-1.57 $-1.26 $-1.34
Mar 2023 0 / 0 $-1.33 $-1.36 $-1.42

IMVT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Mar 2022 7 $0.00 $0.00 $0.00
Mar 2023 6 $0.00 $0.00 $0.00

IMVT Earnings Date & Revenue History

IMVT Earnings History

|
Show More
Show More

IMVT Revenue History

|
Show More
Show More

Immunovant, Inc Next Earnings Date & Report

IMVT Next Earnings Date & Report Preview: Sep 2021 (FQ)

IMVT's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Immunovant, Inc's next quarterly earnings is $-0.28, with a low EPS estimation of $-0.35, and a high estimation of $-0.22.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.28, the last 2 month trend is $-0.28, and the 3 month trend is $-0.33.

Based on 7 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Immunovant, Inc Previous Earnings Dates & Reports

IMVT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Immunovant, Inc's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

IMVT's earnings per share (EPS) was $-0.31, beating the consensus analysts forecast of $-0.32 by 2.12%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 6.90%, and higher than the same period a year before (Jun 2020) by -18.42%.

Revenues were $0.00.

The company reported a net income of $-30.47M.

Free cash flow for the quarter was $-21.23M , compared to $-22.59M last quarter and $-13.85M a year before.

IMVT ended the quarter with $3.06M in total debt, a decrease of -10.54% compared to the previous quarter, and a decrease of -24.96% compared to the same quarter a year before.

IMVT Previous Earnings Date & Report Recap: Mar 2021 (FY)

Immunovant, Inc's previous annual earnings date was Jun 1, 2021 for its fiscal year ended Mar 31, 2021.

IMVT's earnings per share (EPS) was $-1.24, beating the consensus analysts forecast of $-1.29 by -3.88% , and lower than the previous year's EPS (Mar 2020) by 87.88%.

Revenues were $0.00.

The company reported a net income of $-107.43M.

Immunovant, Inc reported a free cash flow of $-83.54M for its fiscal year, compared to $-53.39M a year ago.

The company ended the fiscal year with $3.42M in total debt. lala